Delivery Order SPE2DB22D2211-SPE2DB24FMPK8
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $3,311.50 order is for the delivery of ESBRIET 801 MG TABLET 90S, a pharmaceutical product, with a completion date of February 13, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp has an extensive history of providing...
- This is a federal delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $3,311.50 fixed-price contract is for the delivery of ESBRIET 801 MG TABLET 90S, a pharmaceutical product, with a performance period ending on October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and Department...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide ESBRIET 801 MG TABLET 90S, a pharmaceutical product, with a potential value of $9,934.50 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received numerous federal contract awards to supply...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,311.50 order is for the supply of ESBRIET 801 MG TABLETS 90S, a pharmaceutical product, with a completion date of January 19, 2024. The contract has no set-aside designation. Amerisourcebergen Drug Corp has previously received multiple pharmaceutical and medical supply delivery orders...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The $9,934.50 order is for the delivery of ESBRIET 801 MG TABLET 90S, a pharmaceutical product, with a completion date of January 11, 2024. The award was made on December 19, 2023 and did not utilize any set-aside designations. Amerisourcebergen Drug Corp has a...
- This is a $3,311.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of ESBRIET 801 MG TABLET 90S, which are likely a pharmaceutical product. The contract has an ultimate completion date of October 9, 2024. AmerisourceBergen is a major pharmaceutical distributor in the United States and has been awarded numerous federal contracts by defense and civilian agencies to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ESBRIET 801 MG TABLET 90S, with a potential value of $3,311.50 and a completion date of January 23, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor providing pharmaceutical products and services to U.S. government agencies, primarily the Department of...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product. The firm fixed price delivery order has a potential value of $3,311.50 and a completion date of January 23, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp has a history of providing pharmaceuticals, medical supplies, and...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order, valued at $6,623.00, is for the delivery of ESBRIET 801 MG TABLET 90S to a location in Conshohocken, Pennsylvania by February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this contract....
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $3,311.50 contract is for the delivery of ESBRIET 267 MG CAPSULE 270S, a specialty pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMPK8Delivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $3,311.50 contract is for the delivery of 270 units of the pharmaceutical product ESBRIET 267 MG TABLET. Amerisourcebergen Drug Corp provides a range of pharmaceutical products and medical supplies to support DLA Troop Support Medical facilities and programs. This delivery order does not have a set-aside designation and is expected to be completed by February 5, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division, valued at up to $750,000 through May 2024, to provide medical supplies and prescription medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 1/12/24 |